Figure 2.

Approaches for genome-wide screening and measurement of T cell reactivity. Schematic design for the screening of BP whole genome using different assay modalities (AIM versus ELISpot/FluoroSpot) and strategies (in vitro versus ex vivo) to capture T cell-specific responses.